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Abstract  GH
Despite their different origins, Drosophila glia and hemocytes are related cell populations GI
that provide an immune function. Drosophila hemocytes patrol the body cavity and act as GJ
macrophages outside the nervous system whereas glia originate from the neuroepithelium and GK
provide the scavenger population of the nervous system. Drosophila glia are hence the functional GL
orthologs of vertebrate microglia, cells of immune origin that move into the brain during GM
development and become the resident macrophages of the nervous system. Interestingly, glia and GN
hemocytes require the same transcription factor Glide/Gcm for their development. This raises the HE
issue of how do glia specifically differentiate in the nervous system and hemocytes in the HF
procephalic mesoderm. The Repo homeodomain transcription factor and pan-glial direct target of HG
Glide/Gcm ensures glial terminal differentiation. Here we show that Repo also takes center stage HH
in the process that discriminates between glia and hemocytes. First, Repo expression is repressed HI
in the hemocyte anlagen by mesoderm-specific factors. Second, Repo ectopic activation in the HJ
procephalic mesoderm is sufficient to repress the expression of hemocyte-specific genes. Third, HK
the lack of Repo triggers the expression of hemocyte markers in glia. Thus, a complex network of HL
tissue-specific cues biases the potential of Glide/Gcm. These data allow us to revise the concept of HM
fate determinants and help us understanding the bases of cell specification.  HN
 IE
 IF
Significance statement  IG
Distinct cell types often require the same pioneer transcription factor, raising the issue of IH
how does one factor triggers different fates. In Drosophila, glia and hemocytes provide a scavenger II
activity within and outside the nervous system, respectively. While they both require the IJ
 H
Glide/Gcm transcription factor, glia originate from the ectoderm, hemocytes from the mesoderm. IK
Here we show that tissue-specific factors inhibit the gliogenic potential of Glide/Gcm in the IL
mesoderm by repressing the expression of the homeodomain protein Repo, a major glial-specific IM
target of Glide/Gcm. Repo expression in turn inhibits the expression of hemocyte-specific genes IN
in the nervous system. These cell-specific networks secure the establishment of the glial fate only JE
in the nervous system and allow cell diversification. JF
 JG
 JH
Introduction  JI
In the Drosophila embryo, lateral glial cells (called glia throughout the text, for the sake of JJ
simplicity) constitute the second major population of the nervous system and are necessary for JK
neuronal development, function and survival. Typically, they insulate the central nervous system JL
(CNS) upon forming the blood-brain barrier (BBB) and regulate neurotransmitter recycling, axon JM
guidance or neural proliferation (Trébuchet and Giangrande, 2012). During development and upon JN
injury, Drosophila glia also act as scavenger cells and help reshaping the nervous system. Thus, KE
Drosophila glia behave like microglia, vertebrate immune cells of mesodermal origin that move KF
from the yolk sac into the brain during development and provide the resident macrophages of the KG
CNS (Logan and Freeman, 2007; Kurant, 2011). Outside the fly nervous system, hemocytes play KH
a key role in cellular and humoral immunity. They can move very fast to patrol the organism and KI
respond to a variety of challenges. The most represented subtype of hemocytes, called KJ
plasmatocytes, phagocyte microbes and sculpt tissues by clearing apoptotic cells during KK
development (Meister and Lagueux, 2003).  KL
 I
In addition to sharing the immune function, glia and hemocytes express the same KM
transcription factor, the atypical zinc finger protein Glial cells deficient/Glial cells missing KN
(Glide/Gcm, Gcm throughout the text) (Mao et al., 2012; Cattenoz and Giangrande, 2013) at early LE
stages of their development. Gcm is necessary and sufficient to induce gliogenesis and is required LF
for hemocyte differentiation (see (Cattenoz and Giangrande, 2014) for a review). Thus, the same LG
transcription factor works in functionally related cells that originate from the neurogenic ectoderm LH
(glia) and from the procephalic mesoderm or PM (hemocytes). In the nervous system, Gcm induces LI
the expression of the Reverse polarity (Repo) homeodomain containing transcription factor in all LJ
the glial cells. Repo is necessary for the execution of the glial differentiation program (Yuasa et LK
al., 2003) and embryos lacking Repo do not express late markers (Halter et al., 1995), including LL
the scavenger receptor Draper (Shklyar et al., 2014). As a consequence, repo mutant glial cells are LM
not functional and have defective phagocytic activity (Shklyar et al., 2014). LN
The shared molecular pathway and role of glia and hemocytes call for a cell-specific ME
mechanism triggering embryonic glia and blood differentiation in the correct tissue. We here show MF
that mesodermal cues contribute to prevent glial differentiation in the hemocyte anlagen. The MG
mesodermal transcription factor Twist induces the expression of miR-1, which in turn represses the MH
expression of Repo. As a consequence, the gliogenic potential of Gcm is inhibited in the PM (Xiong MI
et al., 1994; Halter et al., 1995; Yuasa et al., 2003), showing that the potential of a fate determinant MJ
relies on the cell-specific transcriptional landscape. The negative regulation of Repo in the MK
hemocyte anlagen is crucial as Repo represses the hemocyte fate: when expressed in the hemocyte ML
anlagen, it inhibits the expression of hemocyte-specific genes and the lack of Repo induces the MM
expression of early hemocyte markers in the nervous system. Thus, Repo constitutes a major MN
element in the pathway that discriminates between related but distinct scavenger fates.  NE
 J
Altogether, our work dissects the complex network that allows a single pioneer factor to NF
affect different cell fates. NG
 NH
 NI
Results NJ
The mesoderm-specific transcription factor Twist represses the expression of the Repo pan-NK
glial protein NL
The Gcm transcription factor is expressed in the glial as well as in the hemocyte lineages, NM
where it controls the expression of glial and hemocyte genes, respectively (Jones et al., 1995; NN
Bernardoni et al., 1997; Bernardoni et al., 1998; Lebestky et al., 2000; Alfonso and Jones, 2002; FEE
Cattenoz et al., 2016). Since glia differentiate from the ectoderm and hemocytes from the PM, we FEF
hypothesized that tissue-specific factors regulate the expression of the Gcm targets in a cell-specific FEG
manner. Twist (Twi) is an early mesoderm-specific transcription factor and a potent mesodermal FEH
determinant (Baylies and Bate, 1996), we therefore asked whether it represses the expression of FEI
Repo, the most characterized glial-specific target of Gcm. Repo also represents the only FEJ
transcription factor expressed exclusively in glia and in all glia (Halter et al., 1995). FEK
To show that Twi inhibits Repo expression in vivo, we analyzed embryos in which we FEL
induced Twist expression ectopically (Gain Of Function or GOF), in the neural territory, as well FEM
as embryos that lack Twi expression (Loss Of Function or LOF) or express low levels of Twi.  FEN
First, the ectopic expression of Twi in the neurogenic region mediated by the scabrousGal4 FFE
driver (sca>twi) (Mlodzik et al., 1990) significantly reduces the number of Repo positive cells in FFF
the ventral nerve cord from an average of 29.3 +/-1.1 cells per hemisegment in control to 8.6 +/-FFG
1.1 cells in twi GOF embryos (n hemisegments=10, n embryos=3, ANOVA p=8.10-11) (Table 1, FFH
 K
Figure 1 A,B). Second, since the expression of Gcm in the mesoderm triggers gliogenesis at the FFI
expense of muscles (Bernardoni et al., 1998), we performed the same experiment in embryos that FFJ
carry half a dose of Twi and found that this enhances the gliogenic potential of Gcm in the FFK
mesoderm. This data were obtained upon expressing Gcm with the twistGal4 driver (twi>gcm) in FFL
twi/+ heterozygous embryos (Table 1, Figure 1C,D). Third, although Twi is a major mesodermal FFM
determinant that induces severe and early defects when absent (Thisse et al., 1987), it is not FFN
absolutely required for the initial determination of the hemocyte fate (Spahn et al., 2014). This FGE
allowed us to analyze the few twi null embryos that reached relatively late stages and revealed the FGF
presence of the Repo protein in cells that express the early hemocyte marker Serpent (Srp) (no cell FGG
in control and an average of 8.9 +/-4.3 cells Srp and Repo positive per embryo twi LOF, n FGH
embryos=5, Wilcoxon (W) p=0.0038) (Figure 1E,F’’). Unless otherwise specified, low FGI
magnifications of all the figures show confocal projections whereas high magnifications of the FGJ
insets shown single confocal sections, for the sake of simplicity. This explains why the labeling in FGK
the insets corresponds partially to that shown in the low magnification panels. Altogether, our FGL
results strongly suggest that the lack of Twi allows ectopic Repo expression in the hemocyte FGM
anlagen, the PM, hence biasing the gliogenic potential of Gcm in that territory.  FGN
We then asked whether over-expressing Gcm in its own domain of expression, the PM, FHE
leads to the differentiation of supernumerary hemocytes or whether it bypasses the molecular brake FHF
imposed by Twi, hence allowing ectopic Repo expression. For this purpose, we crossed a gcmGal4 FHG
driver with a transgenic line expressing the Gal4 inhibitor Gal80 in glial cells, the other territory FHH
of Gcm expression (Table 1, gcmGal4, repoGal80 or gcm(hemo)Gal4) (Lee and Luo, 1999), so as FHI
to confine Gcm overexpression to the PM (Figure 1G). gcm(hemo)>gcm embryos do display Repo FHJ
expression in the hemocyte anlagen and this is a dosage dependent phenotype, the stronger the UAS FHK
gcm transgene, the higher the levels of Repo (Figure 1H). Moreover, and in line with our FHL
 L
hypothesis, co-over-expressing Gcm and Twi (gcm(hemo)>gcm + twi) abolishes the induction of FHM
Repo expression in the PM (Figure 1I). FHN
The fact that Gcm over-expression induces Repo expression in the PM could mean that glial FIE
differentiation simply requires higher Gcm levels than hematopoiesis. If that were the case, FIF
hypomorphic gcm mutant embryos should express hemocyte markers in the nervous system. The FIG
gcm34 mutation is an imprecise excision that still expresses the LacZ gene carried by the P element FIH
located at the gcm locus and results in low Gcm levels (Vincent et al., 1996). Neither gcm34 FII
homozygous nor gcm34/Df(2L)132 transheterozygous animals (the Df(2L)132 deficiency FIJ
completely deletes the gene (Kammerer and Giangrande, 2001)) show Srp ectopic expression in FIK
the nervous system (Figure 1J-L). This excludes mere dosage dependency for the establishment FIL
of the glial vs. the blood cell fate and further supports the idea that tissue-specific factors are FIM
responsible for it.  FIN
In sum, the Twist mesodermal factor negatively affects the expression of the pan-glial FJE
transcription factor Repo. FJF
 FJG
The micro RNA miR-1 inhibits Repo expression post-transcriptionally FJH
The microRNA miR-1 is a direct target of Twi expressed and required in the mesoderm FJI
(Biemar et al., 2005; Sokol and Ambros, 2005). We found that miR-1 has two putative target sites FJJ
in the repo 3’UTR (miRanda: http://www.microrna.org/microrna/home.do) (Figure 2A) and FJK
therefore explored the possibility that it acts post-transcriptionally on Repo. First, we found that FJL
animals lacking miR-1 display ectopic Repo expression in the PM, similar to the twi embryos FJM
(Figure 2B-D). Second, we asked whether miR-1 directly acts on the repo 3’UTR by co-FJN
transfecting S2 Drosophila cells with a miR-1 expression vector and a luciferase reporter carrying FKE
either the repo 3’UTR or its own 3’UTR (Figure 2E). By measuring the luciferase activity, we FKF
 M
found that miR-1 specifically acts on the repo 3’UTR to repress repo expression (Figure 2E-F). FKG
Third, this negative control is abolished upon mutagenizing the two putative miR-1 target sites FKH
(Figure 2F). Thus, miR-1 inhibits Repo expression post-transcriptionally.  FKI
In sum, our data indicate that mesoderm-specific cues prevent Gcm from triggering Repo FKJ
expression in the PM.  FKK
 FKL
Repo is sufficient to repress the expression of hemocyte markers in the PM FKM
The tight repression of Repo expression in the hemocyte anlagen suggests that gliogenesis FKN
is alternative to hemocyte differentiation. We therefore analyzed the effects of Repo ectopic FLE
expression in the PM upon using the UAS-repo transgene (Yuasa et al., 2003). gcm(hemo)>repo FLF
(or repo GOF) hemocytes are severely affected: many of them aggregate and show altered FLG
morphology as well as migratory defects (Figure 3E,F). Moreover, they no longer express the late FLH
hemocyte marker NimC/P1, which is a scavenger receptor (Kurucz et al., 2007) (Figure 3C,D), FLI
and the expression of the early hemocyte marker Srp is severely downregulated (Figure FLJ
3A’’,A’’’,B’’,B’’’). The hemocytes express Srp at low levels. To quantify this phenotype, we FLK
measured the intensity of Srp labeling and found a significant difference between control and repo FLL
GOF hemocytes (control: 83.4 +/-3.9 arbitrary unit (AU, see materials and methods), repo GOF: FLM
12.4 +/-1.5 AU; n=50 cells in 3 embryos, ANOVA p=6.10-23). Of note, Srp is also expressed in the FLN
fat body and yet such expression remains unchanged in repo GOF animals (Hoshizaki et al., 1994) FME
(Figure 3A’,B’), showing that the hemocyte defects are specific and cell autonomous.  FMF
A more direct evidence for the specific effects of Repo on the srp gene was obtained by FMG
using a Gal4 plasmid that carries a fragment of the srp promoter specific to hemocytes and called FMH
srp(hemo)> (Bruckner et al., 2004). Co-transfecting S2 Drosophila cells with a Repo expression FMI
vector and the srp(hemo)>GFP plasmid severely reduces the expression of the GFP, and this is a FMJ
 N
dosage dependent effect (Figure 3I). Moreover, srp(hemo)>repo embryos display similar features FMK
than gcm(hemo)>repo embryos, with reduced number of hemocytes (Figure 3J-K’’). Indeed, we FML
found 252.8 +/-27.4 hemocytes in control and 136.8 +/-19.8 in repo GOF embryo (n=7 embryos, FMM
ANOVA p=0.0028, counted on 30µm stacks of confocal images taken from stage 13 embryos FMN
(lateral views)). Of note, the presumptive hemocytes that ectopically express Repo with the FNE
gcm(hemo)> or with the srp(hemo) driver do not express late glial markers (as monitored by the FNF
Nazgul antibody (von Hilchen et al., 2010; Ryglewski et al., 2017) (Figure 3E-F’’,J-K’’). FNG
The reduction in the number of hemocytes in repo GOF is due, at least partially, to enhanced FNH
cell death, as shown by the apoptosis marker cleaved death caspase-1 (DCP-1) (Song et al., 1997) FNI
(Figure 3G-H’’, 9.1% +/-1.3 of hemocytes display co-labeling with DCP1 in control vs. 16.1% FNJ
+/-2.1 in repo GOF embryos, n=7 embryos, ANOVA p=0.0150). FNK
Altogether, the above data strongly suggest that the expression of the Repo pan-glial factor FNL
in the PM is detrimental to hemocyte differentiation and are also in line with the fact that Repo is FNM
not sufficient to induce the glial fate when ectopically expressed (Yuasa et al., 2003). FNN
Given the ability of Gcm over-expression in the PM to induce Repo ectopic expression, we GEE
re-examined that phenotype, in order to understand the relative roles of the two transcription factors GEF
in blood and glial development. Interestingly, the over-expression of Gcm in the PM induces both GEG
Repo and Nazgul expression in the presumptive hemocytes (von Hilchen et al., 2010) (Figure 4A-GEH
D’’’, 21.7%+/-3.4 of Repo positive hemocytes/embryo, n=4 embryos, W p=0.0105 and 53.4% +/-GEI
6.4 Nazgul positive hemocytes/embryo, n=3 embryos, W p=0.0318 in gcm(hemo)>gcm, compared GEJ
to 0% in control). Moreover, the cells that express Repo also express the hemocyte marker Srp GEK
(Figure 4E-E’’’) (Rehorn et al., 1996), at levels that are comparable to those found in wild-type GEL
embryos (the intensity of Srp labeling in hemocytes from control = 83.4 +/-3.9 AU and from GEM
gcm(hemo)>gcm = 73.1 +/-6.2 AU, n=50 hemocytes in 3 embryos, ANOVA p=0.22). Thus, Gcm GEN
 FE
over-expression induces the expression of glial genes without blocking hemocyte differentiation. GFE
Since Srp constitutes an early hemocyte gene (Reuter, 1994; Bernardoni et al., 1997; Lebestky et GFF
al., 2000), we asked whether late hemocyte markers are also detected in those cells or whether GFG
hematopoiesis is blocked at its early stages. The hemocyte-specific scavenger receptor Croquemort GFH
(Crq) (Franc et al., 1996; Franc et al., 1999) co-localizes with the pan-glial maker Repo (Figure GFI
4F-F’’’), indicating a mixed glial and hemocyte phenotype. This finding is in accord with the GFJ
expression/requirement of Gcm in both hemocytes and glia. Of note, we never observed Repo GFK
expression in gcm(hemo)>gcm hemocytes at larval stages, suggesting that the Repo expressing GFL
cells do not survive or that Repo expression is not maintained. Finally, because the gcmGal4 driver GFM
is expressed transiently and early in the hemocyte lineages, we confirmed these data by using GFN
additional hemocyte-specific drivers: srp(hemo)Gal4, hemolectinGal4 and hemeseGal4 (Bruckner GGE
et al., 2004) (data not shown).  GGF
 GGG
Repo represses the expression of hemocyte markers in glial cells GGH
 Given the ability of Repo to inhibit the hemocyte fate in the PM, we asked whether it also GGI
represses that fate in glial cells. In the simplest view, the lack of Repo could transform glial cells GGJ
into hemocytes, as glia represent the resident macrophages of the nervous system. By analyzing GGK
the role of Repo first in ectopic glial cells and then in endogenous glia, we found that this GGL
transcription factor represses the expression of hemocyte markers.  GGM
First we found that Gcm expression throughout the neurogenic region (sca>gcm) triggers GGN
ectopic gliogenesis, whereas the same experiment in repo null embryos (repo loss-of-function, GHE
repo LOF) triggers ectopic Srp expression within the nervous system. (Figure 5A-B’’’). To GHF
identify the cells expressing Srp ectopically, we needed a lineage marker that traces the glial cells GHG
in wild-type embryos and the presumptive glia in embryos lacking Repo. We hence analyzed GHH
 FF
sca>gcm; repo LOF embryos that also carry the repo-nuclearGFP (repo-nGFP) transgene, which GHI
faithfully recapitulates the expression profile of Repo. Since Srp is a nuclear marker, using the GHJ
nuclear GFP tagging we could show Srp/GFP co-localisation (Figure 5A-B’’’): 3.5 +/-0.8 GHK
cells/hemisegment show Srp/GFP co-localisation in sca>gcm;repo LOF,repo-nGFP embryos as GHL
compared to 0 cells in sca>gcm;repo-nGFP embryos (n=6 hemisegments in 3 embryos, W p=2.10-GHM
4). This indicates that the presumptive glia express Srp, as opposed to the possibilities that repo-GHN
GFP positive cells phagocyte Srp positive cells (Jones, 2005; Laneve et al., 2012) or that the lack GIE
of Repo induces Srp expression non autonomously. Similar results were obtained upon using a GIF
second early hemocyte marker, U-shaped (Ush) (Figure 5C-D’’’): 6.8 +/-0.6 cells/hemisegment GIG
show Ush/GFP co-localisation in sca>gcm;repo LOF,repo-nGFP embryos as compared to 2.8+/-GIH
0.7 cells in sca>gcm;repo-nGFP embryos (n=10 hemisegments in 3 embryos, ANOVA p=6.10-4). GII
Within the neural tissue, we also found Srp or Ush positive cells that are GFP negative (empty GIJ
arrowheads in Figure 5B’-B’’’,D’-D’’’). These cells likely represent hemocytes that have moved GIK
into a neural tissue that is no longer properly formed/insulated (Shklyar et al., 2014). GIL
Second, we found that Repo is sufficient to repress the expression of hemocyte genes in GIM
endogenous glia. We introduced the srp(hemo)>CD8GFP transgene in repo LOF, repo-nRFP GIN
animals and found GFP expression (hemocyte tracer) in a fraction of RFP positive cells (glial GJE
tracer) in the repo LOF embryos (Figure 6A-C’’). This does not occur in control animals and is in GJF
agreement with the finding that Repo represses the expression of the srp(hemo) promoter in S2 GJG
cells (Figure 3I). Because the GFP of the srp(hemo)>GFP line is localized in the membrane and GJH
the RFP of the repo-nRFP line in the nuclei, we could not formally exclude the possibility that the GJI
co-localization indicated the presence of hemocytes within the mutant nervous system and GJJ
engulfing the presumptive glia. We hence used the anti-Srp antibody and again found expression GJK
of the hemocyte marker in presumptive glial cells (repo LOF, repo-nGFP) (Figure 6E,F). In GJL
 FG
similar assays, we found nuclear co-localization between Ush labeling and GFP (Figure 6G,H). In GJM
total, 11,6 % of the presumptive glia (GFP positive cells) express Srp (2.2 +/-0.8 cells per GJN
hemisegment are double positive GFP/Srp, n=10 hemisegments in 3 embryos, W p= 0.0105) and GKE
26 % express Ush ectopically (4.9 +/-0.5 cells per hemisegment are double positive GFP/Ush, n=3 GKF
hemisegments in 3 embryos, W p= 0.009). This reveals for the first time a hematopoietic potential GKG
for Drosophila embryonic glial cells.  GKH
In addition, we analyzed the expression of another hemocyte marker by labelling the repo GKI
LOF; repo-nGFP embryos with the Singed antibody. singed (sn) codes for a Fascin ortholog that GKJ
is crucial for hemocyte migration (Zanet et al., 2009) and the antibody strongly labels the GKK
embryonic hemocytes (Figure 6I-L’’). The repo LOF embryos show Sn labeling in 6% of the GFP GKL
positive cells. (Figure 6I-L’’). As in the assays performed on ectopic glia, we also found Sn GKM
expressing cells that corresponds to hemocytes migrating into the defective nervous system (Sn GKN
positive/GFP negative cells, Figure 6M-N’). GLE
Finally, we asked whether the lack of Repo converts glial cells into mature and functional GLF
hemocytes by monitoring the expression of the hemocyte-specific phagocytosis receptor Crq GLG
(Franc et al., 1999), but found no ectopic expression of that protein (Figure 6O,P), in agreement GLH
with the hypothesis that the lack of Repo does not simply reveal a default hemocyte fate. Thus, the GLI
lack of the Repo transcription factor triggers the epxression of subsets of hemocyte markers in a GLJ
fraction of presumptive glia. This could mean that Repo is not sufficient to repress a hemocyte fate GLK
in all glial cells or that distinct glial subtypes express different hemocyte markers in the repo LOF GLL
embryos. To discriminate between the two hypotheses, we followed the approach described by GLM
Sklyar et al. (Shklyar et al., 2014) and subdivided the ventral nerve cord in two parts along the Z GLN
axis: the ventral part mainly contains cortex glial cells, the dorsal part mainly contains axon-GME
associated glial cells (Ito et al., 1995) (Figure 6D). The presumptive glia ectopically expressing GMF
 FH
the hemocyte transcription factors Srp or Ush are only located dorsally and they correspond to the GMG
axon-associated glia. This was confirmed by using anti-Fas2, which recognizes the three dorsally GMH
located longitudinal axonal fascicles of the ventral cord (Santos et al., 2007) (Figure 6E,F) or a GMI
second neuronal marker, anti-HRP (Figure 6G,H). On the other hand, the cells that express Sn are GMJ
located at the position of the cortex glia and are mostly located ventrally (Figure 6I-L’’). This GMK
phenotype matches the observation that cortex glia are more motile in repo mutant embryos GML
(Shklyar et al., 2014). GMM
In sum, Repo represses the expression of distinct hemocyte markers in specific glial GMN
subtypes, hence revealing the complexity of this cell population. GNE
 GNF
Repo acts as the guardian of the glial fate GNG
The fact that only a fraction of the presumptive glia expresses any hemocyte marker in repo GNH
LOF embryos prompted us to ask whether these cells display other defects. Since Gcm represses GNI
the neuronal fate and gain of function experiments suggest that Repo contributes to the process GNJ
(Yuasa et al., 2003), we explored the possibility that glial cells lacking Repo express neuronal GNK
features. We indeed found that a fraction of the presumptive glial cells (22 %) express the pan-GNL
neuronal marker Elav (Yao and White, 1991; Berger et al., 2007) in repo LOF; repo-nGFP GNM
embryos (Figure 7A-D’’’,F). These cells are scattered throughout the ventral nerve cord (Figure GNN
7B,D) and do not co-express the hemocyte markers Srp (Figure 7E-E’’’) or Ush (data not shown).  HEE
We hence ypothesized that the neuronal and the hemocyte transcriptional programs may HEF
compete with each other and asked whether hemocyte markers are ectopically expressed in the HEG
ventral cord of embryos lacking Elav, a key factor for neuronal differentiation. No mutant HEH
phenotype was observed in these embryos (last column in Figure 7F,G). Interestingly, however, HEI
elav;repo LOF double mutant embryos that also carry the repo-nGFP transgene show twice as HEJ
 FI
many cells expressing the Srp hemocyte marker in presumptive glia as compared to those observed HEK
in repo LOF embryos (23 % vs. 11% (3rd and 2nd columns, respectively, in Figure 7F,G). Thus, HEL
the glial factor Repo contributes to repress the neuronal as well as the hemocyte fates and the HEM
neuronal factor Elav contributes to repress the hemocyte fate. HEN
To further our understanding on the role of the Repo transcription factor on the glial fate, HFE
we also scored the total number of presumptive glia and assessed their proliferative and cell death HFF
profile in repo LOF embryos. The number of nuclei expressing the GFP in repo LOF; repo-nGFP HFG
embryos is 30 % lower compared to that observed in wild-type animals (345.8+/-6.9 per embryo HFH
in WT compared to 196.0+/-35.8 in repo LOF, n=3 embryos, ANOVA p=0.0383). This is in HFI
agreement with a slight reduction in cell division and a slight increase in apoptosis: anti-PH3 (Juan HFJ
et al., 1998) was used to score for glial cell division: 4.9+/-1.0 dividing cells are present per 6 HFK
hemisegments in WT embryos compared to 0.3+/-0.3 in repo LOF (n=3 embryos, W p=0.0361). HFL
Apoptosis was scored using the anti-CM1 antibody that recognizes the activated Caspase-3 (Figure HFM
8A-B’’’). No cells were observed in WT compared to 10.6+/-1.2 dying cells in repo LOF (n=3 HFN
embryos, 6 hemisegments were counted per embryo, W p=0.0318). It is therefore likely that some HGE
cells missing the Repo protein no longer acquire/maintain the right identity and eventually die. To HGF
make sure that the co-localization between the presumptive glia (nuclear GFP) and the death maker HGG
CM1 identifies dying cells (Figure 8A-B’’’,E), rather than glial cells that are phagocytosing dead HGH
bodies, we compared the results obtained on repo LOF; repo-nGFP with those obtained on repo; HGI
repo-CD8GFP embryos, in which the GFP is tagged to the membrane (Figure 8E).  HGJ
As expected, in the latter case we did not observe co-localization between the GFP and HGK
CM1 (Figure 8C-C’’’). Moreover, this data further confirmed the lack of phagocytosis observed HGL
in repo LOF embryos (Figure 8D), likely due to defective SIMU and Draper expression (Shklyar HGM
 FJ
et al., 2014). Indeed, while in wild-type embryos glial cell membranes completely enwrap apoptotic HGN
bodies (Figure 8C-C’’’), in repo LOF embryos these contacts are no longer established. HHE
In sum, Repo acts as a true guardian of the glial fate, in line with the fact that it is the only HHF
transcription factor that is expressed in all glia and only in glia. HHG
 HHH
 HHI
Discussion  HHJ
 During development, pioneer transcription factors trigger specific cell fates. More and more HHK
data however show that these factors act in multiple lineages, raising the question of how does each HHL
lineage differentiate at the right place. Here we show that a pioneer factor acts in concert with HHM
tissue-specific cues to trigger distinct fates in different territories and that this distinction is HHN
maintained through reinforcing inhibitory pathways. The Drosophila Gcm zinc finger protein HIE
promotes hematopoiesis in the procephalic mesoderm and gliogenesis in the nervous system. The HIF
expression of its target and pan-glial transcription factor Repo is repressed in the hematopoietic HIG
anlagen by mesodermal cues. In turn, Repo represses the expression of hemocyte genes. These HIH
sequential regulatory steps explain how Gcm induces two functionally related but alternative cell HII
fates in different territories.  HIJ
 HIK
Tissue-specific cues inhibit the gliogenic potential of Gcm in the hematopoietic anlagen HIL
The Drosophila transcription factor Gcm is expressed and required for the differentiation HIM
of glia and blood, which share immune features but also perform specific functions in the immune HIN
and nervous systems. These cells originate from different layers, glia from the ectoderm, hemocytes HJE
from the mesoderm, and therefore display distinct molecular landscapes. We here show that the HJF
 FK
mesoderm-specific transcription factor Twi and its target miR-1 repress the expression of the pan-HJG
glial gene Repo in the hemocyte anlagen. Thus, the mesodermal molecular landscape controls Gcm HJH
activity and biases its transcriptional output towards hemocyte differentiation. HJI
The coordinated activity of pioneer and tissue-specific factors allows a limited number of HJJ
transcription factors to produce the high diversity of cell types present in complex organisms. For HJK
example, the vertebrate GATA transcription factors regulate the development of hematopoietic, HJL
neural, cardiac or reproductive tissues (Cantor and Orkin, 2005; Zaytouni et al., 2011; Chlon and HJM
Crispino, 2012) and control specific target genes in the different tissues due to the activity of tissue-HJN
specific transcription factors that modify the transcriptional output of the GATA factors (Cantor HKE
and Orkin, 2005). It will be interesting whether in that case as well post transcriptional regulation HKF
contributes to the acquisition of cell specificity. HKG
 HKH
The Repo homeodomain containing factor locks cells in the glial fate HKI
Gcm is expressed and necessary at early stages of glial development, whereas the HKJ
homeodomain containing Repo protein is stably expressed in the glial cells. The lack of late glial HKK
markers observed in repo mutant embryos initially suggested a role of Repo in glial terminal HKL
differentiation (Xiong et al., 1994; Yuasa et al., 2003). However, the ectopic expression of non-HKM
glial markers in those embryos shows that Repo also controls cell plasticity. This shows that HKN
homeodomain containing transcription factors can provide the molecular relay from multipotency HLE
to a fully differentiated state once the transient expression of pioneer factors extinguishes.  HLF
The robustness of the glia and hemocyte fates relies on the activity of cell-specific genes: HLG
Repo as well as Elav repress the expression of Srp in the nervous system, whereas Twi/miR-1 HLH
repress the expression of Repo in the mesoderm. Moreover, Srp and Gcm co-expression in the HLI
 FL
mesoderm also repress Repo expression (data not shown). These inhibitory interactions ensure HLJ
that the glial and the hemocyte fates are mutually exclusive. HLK
Our data also suggest that glial (Repo) and neuronal (Elav) factors both repress ectopic HLL
hematopoiesis in the neural territory while counteracting each other to maintain the glial and the HLM
neuronal fates, respectively. This molecular network explains why cells adopt the neuronal default HLN
fate in the absence of Gcm whereas they start expressing hemocyte markers in the absence of Repo, HME
and even more so in the absence of both Repo and Elav. HMF
Thus, cell-specific pathways and feedback loops allow a single pioneer factor to affect HMG
different cell fates. Such molecular checkpoints acting in parallel and in sequence allow the HMH
maintenance of a stable fate. HMI
 HMJ
Lack of Repo triggers different phenotypes in distinct glial subtypes HMK
The glial cells of the embryonic ventral nerve cord are subdivided into three main subtypes HML
(surface, cortex and axon-associated) based on their morphology, position and function (Ito et al., HMM
1995; Beckervordersandforth et al., 2008). The large and flattened glial cells associated to the HMN
surface form the BBB (Auld et al., 1995). Glial cells located in the cortex are star-shaped and HNE
intermingled with neuronal bodies, their cytoplasmic projections contacting multiple synapses HNF
(Freeman and Doherty, 2006; Freeman, 2015). Cortex glia help clearing the debris induced by HNG
neuronal programmed cell death (Freeman et al., 2003; Shklyar et al., 2013; Shklyar et al., 2014) HNH
(Kurant et al., 2008). Finally, glial cells associated to the axons enwrap them in a multi-layer sheath HNI
promoting the conduction of nerve impulses and a subset of them has also been called astrocyte-HNJ
like glia (Hidalgo and Booth, 2000; Sepp et al., 2000; Sepp and Auld, 2003; Freeman and Doherty, HNK
2006; Freeman, 2015). These glia are known to act as scavengers in response to developmental HNL
signals and to trauma, likely due to their proximity to signaling axons. Typically, in the adult brain HNM
 FM
they phagocyte degenerating axons after brain injury (Doherty et al., 2009) and, after puparium HNN
formation, axon-associated glia of the mushroom body control ecdysone-dependent axons pruning IEE
(Awasaki and Ito, 2004; Kato et al., 2011; Kato and Hidalgo, 2013; Boulanger and Dura, 2014; IEF
Hakim et al., 2014).  IEG
Repo is expressed in the three cell types and its lack affects them all (Giesen et al., 1997; IEH
Yuasa et al., 2003; Kerr et al., 2014), however the repo mutant phenotypes reveal the underlying IEI
diversity of the glial subtypes as, in the absence of Repo, axon-associated glia express early IEJ
hemocyte transcription factors but not Sn, whereas cortex glia express Sn, but not the Srp or Ush IEK
transcription factors. Of note, Sn is necessary for cell motility (Adams, 2004; Zanet et al., 2009) IEL
and Kurant and collaborators (Shklyar et al., 2014) observed that repo mutant cortex glia are very IEM
motile. In the future, it will be interesting to determine the transcriptional landscape of the different IEN
glial subtypes as, for example, cortex glia may be specialized in removing dead cell bodies whereas IFE
axon-associated glia may specifically target and remove axons and dendrites. IFF
Finally, our data strongly suggest that, although glial cells act as macrophages, they do not IFG
have a default hemocyte phenotype, rather, they constitute a very specialized population of IFH
scavenger cells. Similarly, vertebrate microglia, cells of immune origin that provide the first IFI
response to nervous system challenge, display a molecular signature that is distinct from that of IFJ
macrophages (Prinz and Priller, 2014).  IFK
 IFL
Of flies and vertebrates…  IFM
Drosophila and vertebrate glial cells share numerous functions controlling neuron IFN
homeostasis, recycling neurotransmitters and insulating axons (Freeman and Doherty, 2006), IGE
however the transcriptional program triggering the first steps of gliogenesis are not evolutionarily IGF
 FN
conserved. In Drosophila, the Gcm transcription factor constitutes the major regulatory gene and IGG
acts as a molecular switch between neuron and glial cells. Although the vertebrate Gcm orthologs IGH
seem to maintain some gliogenic potential in vitro (Kim et al., 1998; Reifegerste et al., 1999; IGI
Buzanska et al., 2001; Iwasaki et al., 2003; Soustelle et al., 2007), they are neither expressed nor IGJ
required in glia. Moreover, no true glial determinant has been so far identified in vertebrates IGK
(Hitoshi et al., 2011). Even more strikingly, the vertebrate genomes do not contain the coding IGL
sequences for Repo (no orthologs found so far), the only fly transcription factor that is specific to IGM
all lateral glia and only to glia, a molecular signature that seems shared throughout the Arthropod IGN
clade (Wakamatsu, 2004; Boyan et al., 2011; Mysore et al., 2011; Nasu and Hara, 2012). IHE
Our findings raise the question of the evolutionary link between vertebrate and Drosophila IHF
gliogenesis (Hartline, 2011). While the hypothesis of an independent origin of vertebrate and IHG
invertebrate glia remains to be tested, the comparative analysis of those glia has tremendously IHH
improved our understanding of the bases of nervous system regeneration. Drosophila glia indeed IHI
constitute an excellent model to investigate the mechanisms governing CNS repair following IHJ
traumatic injury (Leyssen and Hassan, 2007; Kato et al., 2011). In this contest, and in light of recent IHK
data showing that mature astrocytes and oligodendrocytes can be reprogrammed into functional IHL
neurons to promote CNS regeneration (Heinrich et al., 2010; Guo et al., 2014; Su et al., 2014), it IHM
will be interesting to study whether the loss of Repo triggers glial cell conversion into neurons in IHN
the adult Drosophila injured CNS. IIE
Finally, sequencing the genome and analyzing the single cell transcriptome of simple IIF
organisms has become an important tool to understand the molecular and cellular bases of IIG
evolution. Future analyses will establish when Gcm and Repo appear in evolution and where are IIH
they expressed/required within/outside the nervous system. III
 IIJ
 GE
Materials and Methods IIK
Fly stocks  IIL
 Flies were kept at 25 °C. w1118 was used as wild-type. repo-nGFP was used to drive nuclear IIM
GFP expression under the control of the 4.3kb repo promoter, which recapitulates the full repo IIN
expression pattern (Jones, 2005; Laneve et al., 2012). gcm34 (Bernardoni et al., 1999) was used as IJE
a gcm hypomorphic allele carrying a lacZ insertion. The Df(2L)132 (Kammerer and Giangrande, IJF
2001) deletes the entire gcm locus and was used as a null allele. repo52, repo84 (Xiong et al., 1994; IJG
Halter et al., 1995), twi1 (Castanon et al., 2001) and elav4  (Bloomington Center) are null alleles. IJH
The UAS/Gal4 system was used for cell-specific manipulation of gene expression. IJI
srp(hemo)Gal4 triggers expression in hemocytes (Bruckner et al., 2004), scaGal4 throughout the IJJ
neurogenic region (Bloomington stock Center), twiGal4 (Baylies and Bate, 1996) throughout the IJK
mesoderm and gcmGal4 (Soustelle and Giangrande, 2007) combined to repo-Gal80 (gift of B. IJL
Altenhein) throughout the hemocyte anlagen. Finally, repoGal4 was used to drive gene expression IJM
in glial cells (Lee and Jones, 2005). IJN
The following transgenes were also used: UAS-CD8GFP (targeting GFP expression to the IKE
membrane), UAS-RFP (Bloomington stock Center), UAS-GFP (Bloomington stock Center); UAS-IKF
repo (Yuasa et al., 2003); UAS-twi (Baylies and Bate, 1996); UAS-gcm(F18A) (Figure 5) (weak IKG
Gcm over-expression), UAS-gcm(RS1) (Figure 1C,D,I) or UAS-gcm(M24A) (Figure 1H, Figure IKH
4) (medium Gcm over-expression) (Bernardoni et al., 1998). The combination of UAS-gcm(M24A) IKI
and UAS-gcm(F18A) provided a strong Gcm over-expression (Figure 1H). IKJ
 IKK
 IKL
 IKM
 GF
Immunohistochemistry IKN
 Embryo collections were done on plates containing agar, apple juice and yeast. ILE
Dechorionated embryos were fixed in 4% formaldehyde in PBS for 20 min, permeabilized with ILF
0.3 % Triton-x100 in PBS (PTX), blocked by 0.5% Blocking Reagent (Roche) in PTX for 1 h and ILG
labeled overnight at 4 °C with the following antibodies: rabbit (rb) anti-Repo (1/10), mouse (m) ILH
anti-Repo (1/10), m anti-Singed (1/50) and rat anti-Elav (1/200) (DHSB); guinea pig (gp) anti-ILI
Repo (1/1000) and gp anti-Nazgul, (1/200) (gift of B. Altenhein) (von Hilchen et al., 2010); mouse ILJ
(m) anti-Ush (1/1000) (Cubadda et al., 1997); rb anti-Srp (1/1000) (gift of R. Reuter) (Sam et al., ILK
1996; Petersen et al., 1999); m anti-P1 (1/10) (gift of E. Kurucz) (Kurucz et al., 2007); rb anti-Crq ILL
(1/500) (gift of J.L Dimarcq and J. Hoffmann) (Franc et al., 1996); m anti-Fas2 (1/100) (gift of ILM
C.S. Goodman) (Grenningloh et al., 1991); rb anti-HRP (1/500) and rb anti-β-Gal (1/500) (Cappel) ILN
and chicken anti-GFP (1/1000) (Abcam); m anti-β-Gal (1/200) (Sigma); rat anti-RFP (1/100) IME
(chromotek); rb anti-DCP-1 (1/50) (Cell Signaling Technology). IMF
The secondary antibodies were FITC-, Cy3 or Cy5 conjugated (1/400, Jackson). Images IMG
were taken with the SP2 or the SP5 Leica confocal microscopes and processed using Fiji IMH
(Schindelin et al., 2012).  IMI
Srp signal intensity was measured on confocal images acquired with hybrid detector in IMJ
photon counting mode. The mean gray value measurement tool from Fiji was used to estimate the IMK
intensity of the signal (in Arbitrary Unit, AU) from 50 hemocytes in at least 3 embryos (Schindelin IML
et al., 2012). IMM
 IMN
Co-transfection, Western blot and luciferase assays INE
 Drosophila S2 cells were grown in Schneider medium (Fisher Scientific) complemented INF
with 10% heat inactivated Fetal Calf Serum and 0.5% Penicillin/Streptomycin. 6 x 106 cells were ING
 GG
cultured in six well culture dish 12 h prior transfection. 5 μg of total plasmid mix were transfected INH
using the Effectene Kit (Qiagen) according to manufacturer’s instructions. The psrp(hemo)Gal4 INI
plasmid provided a srp transcriptional reporter (Bruckner et al., 2004) upon co-transfection with INJ
the pUAS-GFP plasmid. The pPac5C-repo plasmid was used to induce Repo expression (Yuasa et INK
al., 2003) and pPac5C-lacZ as a transfection control. The pPac5C plasmid was used to equilibrate INL
the amount of transfected DNA. Cells were harvested 24 h after transfection in Tris-HCl 25 mM INM
pH 7.9, 400 mM KCl, 10 % glycerol and total proteins were extracted by three freezing-thawing INN
steps. Protein expression was detected from protein lysate according to standard Western blot JEE
procedure. The following primary antibodies were used: m anti-β-Gal (1/2500, Sigma), rb anti-JEF
GFP (1/5000, Molecular Probes), m anti-Repo (1/20, DHSB). m anti-HRP and rb anti-HRP JEG
(1/5000, Jackson ImmunoResearch) were used as secondary antibodies.  JEH
For the luciferase assay, Drosophila S2 cells were cultured in a 24-well plate, in the same JEI
conditions as previously described. Plasmid transfections were carried out using Effectene JEJ
(Qiagen) following manufacturer’s instructions. pMTGal4-GFP, pUAST-Luciferase-Luciferase JEK
3’UTR, pUAST-Luciferase-Repo 3’UTR, pUAST-Luciferase-Repo 3’UTR ΔmiR-1 and pTK-Renilla JEL
were all used at 20 ng/mL and pTub-miR-1 was used at 50 ng/mL. The cells were cultured 2 days JEM
prior induction with 500 µM of copper sulphate. The luciferase assay was done 18h after induction, JEN
using the Dual-Glo Luciferase assay kit (Promega) according to manufacturer’s instructions. Three JFE
independent transfections were averaged with standard deviation. Statistical significance was JFF
calculated with Graphpad Prism software using t-test. JFG
 JFH
RNA extraction, reverse transcription and qPCR JFI
Total RNA was purified from stage 5-11 embryos by TriReagent (MRC). 1 μg of purified JFJ
RNA was reverse transcribed by SuperScript II reverse transcriptase (Invitrogen) using oligodT JFK
 GH
primers (5 μM). mRNAs were analyzed by qPCR using Sybr Green (Roche) Master Mix, the JFL
thermocycler Roche LightCycler480 and the following oligonucleotides:  JFM
repo forward : 5’ AAGCAGCAGCAAGAAGAAGG 3’ JFN
repo reverse : 5’ ATACGGAGCACGTTCAAAGG 3’ JGE
actin5C forward : 5’ GCAGCAACTTCTTCGTCACA 3’ JGF
actin5C reverse : 5’ CTTAGCTCAGCCTCGCCACT 3’ JGG
For each gene, the mRNA levels were automatically calculated (LightCycler480 Software, JGH
release 1.5.0) by calibration to gene-specific standard curves generated on input cDNAs. Collected JGI
values, derived from three amplification reactions, each performed in three independent JGJ
experiments, were normalized to actin5C mRNA amounts.  JGK
 JGL
Statistics JGM
All the experiments were performed in at least three biological replicates. Statistical JGN
relevance was assigned by calculating means, standard errors. Whenever the data showed normal JHE
distribution (Figure 1H,I, 3I), they were analyzed by the ANOVA test, whenever they did not JHF
(Figure 7F,G) by Kruskal-Wallis (KW) and Wilcoxon (W) tests. * = p < 0.05; ** = p < 0.01; *** JHG
= p < 0.001. JHH
 JHI
 JHJ
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Table 1 LJE
Drivers used to target the neurogenic region, the mesoderm and the procephalic mesoderm. LJF
The 1st column indicates the genotype, the 2nd column indicates the region expressing the driver LJG
(embryo at stage 8, lateral view, anterior to the left) and in a cross-section of the embryo (dorsal to LJH
the top) and the 3rd column indicates the region targeted. LJI
 LJJ
 LJK
Figure legends LJL
Figure 1: Twi negatively regulates Repo expression. LJM
A-D) Confocal projections of embryos stage 14 scaGal4 or sca> (Control, A), sca>twi (twi GOF, LJN
B), twi>gcm (gcm GOF, C) and twi>gcm;twi-/+ (gcm GOF, twist het, D) immunolabeled for the LKE
glial marker Repo (blue). Ventral view. Unless otherwise specified, all scale bars represent 100 µm LKF
and anterior is to the left. (E-F’’) Confocal projections of wild-type (E) and twi-/- (twi LOF, F) LKG
embryos labeled for the Repo glial marker (blue) and for the hemocyte Srp marker (red). Lateral LKH
view. (F’) and (F’’) represent a single section of the inset indicated in (F), they show Srp labeling LKI
only and co-labeling with Repo, respectively. The white arrowheads indicate cells expressing Srp LKJ
and Repo. (G) Confocal projections of gcmGal4,repoGal80/+;UAS-CD8GFP (gcm(hemo)>GFP) LKK
embryos labeled for Repo (blue) and GFP (green). Lateral view (upper panel) and ventral view LKL
(lower panel). The region defined by the dashed line indicates the Central Nervous System (CNS). LKM
Note that GFP expression is excluded from glia. (H,I) Relative quantification of repo mRNA by LKN
qPCR from stage 5-11 embryos of the following genotypes: gcm(hemo)> (Control) and LLE
gcm(hemo)> gcm GOF (Weak, Medium and Strong gcm GOF) in (H); gcm(hemo)> (Control), LLF
gcm(hemo)>medium gcm (Med. gcm GOF) and gcm(hemo)>medium gcm + twi (Med. gcm GOF, LLG
 HF
twi GOF) in (I). gcm levels are relative to actin levels, n indicates the number of independent LLH
assays, see the Experimental Procedure section for the statistic tests. (J-L) Confocal projections of LLI
embryonic ventral cords of the following genotypes: gcm34/+ (J), gcm34/gcm34 (K) and LLJ
gcm34/Df(2L)132 (L). Labeling: β-Gal (green), Srp (red) and the neuronal marker Elav (gray). The LLK
gcm34 line represents a P element partial excision that retains the LacZ gene, allowing monitoring LLL
of gcm expression. β-Gal/Srp double positive cells (yellow, asterisks) are located outside the LLM
ventral cord (dashed line) and label the circulating hemocytes. LLN
 LME
Figure 2: miR-1 prevents Repo expression in the hemocyte lineage. LMF
(A) Schematic representation of the repo locus in the Drosophila genome (dm3). UTRs and coding LMG
exons are indicated by plain blue boxes (thin and thick, respectively) and the intron by a blue line. LMH
The two putative miR-1 binding sites in the repo 3’UTR are indicated. (B,C) Confocal projections LMI
of embryos of the following genotypes: wild-type and miR-1 LOF (-/-), lateral view, stage 14, LMJ
labeled for Repo (blue) and Srp (red). (C’) and (C’’) represent a single section of the inset indicated LMK
in (C), they show Srp labeling only and co-labeling with Repo, respectively. (D) Number of LML
hemocytes expressing Srp and Repo in wild-type and in miR-1 mutant embryos (-/+ and -/-). n LMM
indicates the number of embryos analyzed for each genotype. (E) Schematic representation of the LMN
three Luciferase reporter vectors that were used in the co-transfection assays: the top one is the LNE
Control vector carrying the Firefly Luciferase coding sequence and the Firefly 3’UTR under the LNF
UAS promoter. In the second construct (middle), the 3’UTR has been replaced by the repo 3’UTR LNG
and in the last construct (bottom), the two miR-1 binding sites of the repo 3’UTR have been LNH
mutated. (F) Quantification of the Luciferase activity in extracts from S2 cells co-transfected with LNI
pTub-miR-1, pTK-Renilla and either pUAST-Luciferase-Luciferase-3’UTR (Firefly 3’UTR, gray), LNJ
 HG
pUAST-Luciferase-Repo-3’UTR (repo 3’UTR, green) or pUAST-Luciferase-Repo-3’UTRΔmiR-1 LNK
(repo 3’UTR ΔmiR-1, red), the values are normalized with the Renilla activity.  LNL
 LNM
Figure 3: Repo can repress hemocyte differentiation. LNN
(A-H’’) Embryos gcm(hemo)>CD8GFP (Control) or gcm(hemo)>CD8GFP,repo (repo GOF). MEE
(A,B) represent confocal projections of embryos labeled for GFP (green), Srp (red) and Repo MEF
(blue), dorsal view, stage 16, the empty arrowheads indicate the Srp positive GFP negative cells of MEG
the fat body. (A’) and (B’) show the Srp signal alone. (A’’,A’’’,B’’,B’’’) show single sections of MEH
the insets indicated in (A,B), the arrowheads indicate the hemocytes (GFP/Srp double positive MEI
cells). Note that Repo is expressed in GFP positive cells in repo GOF (B’’) and that the levels of MEJ
Srp upon Repo overexpression (B’’’) are much lower compared to those observed in the wild-type MEK
embryo (A’’’). (C,D) represent confocal projections of embryos labeled for the hemocyte marker MEL
P1 (red), dorsal view, stage 14. (E-F) represent confocal projections of embryos labeled for GFP MEM
(green) and the glial marker Nazgul (red), lateral view, stage 14, (E’,F’) show the Nazgul signal MEN
alone. (G,H) represent single confocal sections of embryos labeled for DAPI (blue), CD8GFP MFE
(green) and the apoptotic marker DCP-1 (gray). (G’,G’’,H’,H’’) show the insets indicated in MFF
(G,H), the arrowheads indicate cells double positive for CD8GFP and DCP-1. (I) Western blot on MFG
protein extracts from S2 cells co-transfected with psrp(hemo)Gal4, pUAST-GFP and increasing MFH
amounts of pPac5C-repo (0 to 3 µg). pPac5C-lacZ was used as a transfection control. The MFI
histogram represents GFP/β-Gal relative quantification. The amounts of transfected Repo were also MFJ
verified. n indicates the number of co-transfection assays. (J-M) Embryos srp(hemo)>RFP MFK
(Control) or srp(hemo)>RFP,repo (repo GOF), lateral view, stage 14. (J,K) represent confocal MFL
projections of embryos labeled for RFP (red) and Repo (green). (J’,K’) show the Srp signal alone MFM
 HH
from (J,K). (J’’,K’’) represent single sections of the insets indicated in (J,K). (L,M) represent MFN
confocal projections of embryos labeled for Nazgul (red). MGE
 MGF
Figure 4: Gcm has a strong gliogenic potential in hemocyte precursors.  MGG
(A-D’’’) Embryos gcm(hemo)>CD8GFP (Control, A,A’C,C’) and gcm(hemo)>CD8GFP,medium MGH
gcm (Medium gcm GOF, B,B’D,D’). (A-B’) represent confocal projections of embryos labeled for MGI
GFP (green) and Repo (blue), lateral view, stage 14. (B’’,B’’’) represent single confocal sections MGJ
of the inset indicated in (B’), the arrowheads indicate cells double positive for CD8GFP and Repo. MGK
(C-D’) represent confocal projections of embryos labeled for GFP (green) and Nazgul (red), lateral MGL
view, stage 16. Brackets indicate territories exhibiting hemocytes. Note that the yellow color MGM
observed in (C’, oval) is an artifact created by the projection. (D’’,D’’’) represent single confocal MGN
sections of the inset indicated in (D’), arrowheads indicate ectopic glial labeling in hemocytes over-MHE
expressing Gcm. (E-F’’’) Single confocal sections of medium gcm GOF MHF
(gcm(hemo)>CD8GFP,medium gcm) embryos labeled for Srp (red), Repo (blue) and GFP (E-E’’’) MHG
and Crq (red), Repo (blue) and GFP (F-F’’’). Hemocytes are indicated by asterisks, those that also MHH
express Repo by arrowheads. Note that Repo ectopic expression does not affect Srp or Crq MHI
expression. Scale bars in (E,F): 50 µm. MHJ
 MHK
Figure 5: Repo represses the Gcm hematopoietic potential in the neuroectoderm.  MHL
(A-D) Confocal projections of embryos sca>weak gcm;repo-nGFP (Weak gcm GOF, A,C) and MHM
sca>weak gcm/repo-nGFP;repo-/- (weak gcm GOF, repo LOF, B,D) labeled for GFP (green) and MHN
Srp (red) (A-B’’’) or GFP (green) and Ush (red) (C-D’’’), ventral view, stage 16. The dashed line MIE
indicates the ventral nerve cord (VNC) (A-D). (B’-B’’’, D’-D’’’) represent single sections of the MIF
insets indicated in (B, D), they show nGFP labeling only, Srp or Ush labeling only and co-labeling MIG
 HI
Srp or Ush with nGFP, respectively. White arrowheads indicate nGFP/Srp (B’-B’’’) or nGFP/Ush MIH
(D’-D’’’) double positive cells, empty arrowheads indicate Srp or Ush positive and nGFP negative MII
cells in gcm GOF repo LOF embryos. These are hemocytes recruited to the VNC that is not MIJ
properly insulated due to the mutant background (Shklyar et al., 2014). MIK
 MIL
Figure 6: Repo is required to repress hemocyte transcription factors in developing glia. MIM
(A,B) Confocal projections of embryos srp(hemo)>CD8GFP/repo-nRFP (Control, A) and MIN
srp(hemo)>CD8GFP/repo-nRFP;repo-/- (repo LOF, B) labeled for GFP (green) and RFP (red), MJE
ventral view. (B’-B’’’, C-C’’) show single sections of the insets indicated in (B). Note that the MJF
single sections were acquired at different focal planes in the VNC. The arrows indicate GFP/RFP MJG
double positive cells. (D) Schematic representation of a transversal section of the VNC from a MJH
mature embryo. Glial cell subtypes are defined according to their localization: surface pale (blue), MJI
cortex (red) and axon-associated glia (green) (Ito et al., 1995; Beckervordersandforth et al., 2008). MJJ
(E-P) Embryos of the following genotypes: repo-nGFP (Control) and repo-/-;repo-nGFP (repo MJK
LOF). The analyses were performed upon subdividing the VNC in a ventral and in a dorsal part, MJL
according to the schematic shown in (D), the position of the section along the dorso/ventral axis of MJM
the VNC is indicated on the left side of the panels. Scale bar in (E-P): 50 µm. Stage 15 embryos MJN
are labeled for GFP (green), Fas2 (gray) and Srp (red) (E,F); GFP (green), HRP (gray) and Ush MKE
(red) (G,H). Stage 14 embryos are labeled for GFP (green) and Sn (red) (I-L’’), (L’,L’’) show MKF
single sections of the inset indicated in (L). (M,N) Confocal projections of the whole VNC labeled MKG
for GFP (green), Sn (red) and Elav (gray), the dash line indicates the position of the z-axis MKH
reconstitution of the VNC presented in (M’,N’). Note the presence of Sn positive/GFP negative MKI
cells within the VNC in repo LOF embryo; these are hemocytes recruited to the VNC following MKJ
the loss of repo (Shklyar et al., 2014). (O,P) Embryos labeled for GFP (green) and Crq (red). MKK
 HJ
 MKL
Figure 7: Repo represses both hemocyte and neuronal differentiation MKM
(A-D’’’) Embryos of the following genotypes: repo-nGFP (Control) and repo-/-;repo-nGFP (repo MKN
LOF), ventral view, stage 15. The ventral and the dorsal parts of the VNC were analyzed separately. MLE
Labeling: GFP (green) and Elav (gray). (B’-B’’’,D’-D’’’) show single sections of the insets MLF
indicated in (B, D). Arrowheads indicate ectopic GFP/Elav double positive cells. (E-E’’’) Dorsal MLG
part of a repo-/-;repo-nGFP (repo LOF) embryo labeled for Srp (red), Elav (gray) and GFP (green), MLH
the channels are presented individually in (E’), (E’’) and (E’’’), respectively. White arrowheads MLI
indicate GFP/Elav double positive cells and empty arrowheads indicate GFP/Srp double positive MLJ
cells. Scale bars in (A,E): 50µm. (F,G) Graphs showing the number and the percentage of MLK
GFP/Elav double positive cells (F) or GFP/Srp double positive cells (G) per hemisegment in MLL
Control, repo LOF, repo LOF elav LOF double mutant and elav LOF embryos. n indicates the MLM
number of hemisegments counted in 3 embryos. MLN
 MME
Figure 8: repo -/- glia undergo apoptosis. MMF
(A-D) Embryos of the following genotypes: repo-nGFP (Control, A) and repo-/-;repo-nGFP (repo MMG
LOF, B) express nuclear GFP. repo-CD8GFP (Control, C) and repo-/-;repo-CD8GFP (repo LOF, MMH
D) express GFP at the membrane, ventral view, stage 15. Labeling: GFP (green) and the apoptotic MMI
marker CM1 (red). (B’-B’’’,C’-C’’’) show single sections of the insets indicated in (B, C). MMJ
Arrowheads in (B’-B’’’) indicate glial cells undergoing apoptosis (co-localisation of nuclear GFP MMK
and CM1), whereas arrowheads in (C’-C’’’) indicate glial cells enwrapping apoptotic bodies MML
(CD8GFP surrounding CM1 labeled bodies). (E) Schematic representation of the GFP/CM1 co-MMM
labelling in apoptotic cells expressing nuclear GFP and in phagocytic cells expressing GFP at the MMN
membrane. MNE
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